t
Imperial Brands PLC announced that on 02 October 2026, it repurchased 210,000 of its ordinary shares for cancellation from Barclays Capital Securities Limited. This transaction, part of its GBP 1.45 billion share repurchase programme, was executed at an average price of GBp 2,442.7991. Following the cancellation, the number of ordinary shares in issue will be 758,914,639 (excluding treasury shares).
| Date | 5 Oct 2026 |
| Time | 09:38:00 |
| Category | Capital structure |
| ID | 6176X |
IMPERIAL BRANDS PLC
Legal Entity Identifier (LEI) No. 549300DFVPOB67JL3A42
Transaction in own shares
Imperial Brands PLC (the "Company") announces that on 02 October 2026 it purchased for cancellation the following number of its ordinary shares of 10 pence each pursuant to its GBP 1.45 billion share repurchase programme, details of which were announced on 7 October 2025.
Description of shares: Imperial Brands PLC - ordinary shares of 10 pence
Number of shares repurchased: 210,000
Date of transaction: 02 October 2026
Average price paid per share: GBp 2,442.7991
Lowest price paid per share: GBp 2,426.0000
Highest price paid per share: GBp 2,459.0000
Broker: Barclays Capital Securities Limited ("Barclays")
The Company intends to cancel these Shares.
All shares were purchased from Barclays as an on exchange transaction subject to the rules of the London Stock Exchange.
Following the purchase and subsequent settlement and cancellation of these shares, the remaining number of ordinary shares in issue will be 758,914,639 (excluding treasury shares).
The figure of 758,914,639 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), detailed information about the individual purchases is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/6176X_1-2026-10-5.pdf
Contacts:
John Crosse +44 (0) 7484967842